Giant mucinous liposarcoma of the abdominal cavity: A case report

Author:

Li Yi-Ming1,Zhu Hai-Hong2ORCID,Wang Xiang-Qian2,Shi Meng-Zhen1,ShangGuan Chao-Liang2

Affiliation:

1. The Graduate School, Qinghai University, Xining, PR China

2. Qinghai Provincial People’s Hospital, Xining, PR China.

Abstract

Rationale: Mucinous liposarcoma myxoid liposarcoma is a malignant mucoid soft tissue tumor derived from undifferentiated stromal cells in perivascular, subbody cavity and intermuscular space, and composed of cells at different stages of differentiation from preadipocytes to mature cells. In rare cases, it may change from lipoma malignancy. The main manifestations is painless mass, relatively slow growth, the course can last decades, the prevalence of liposarcoma in the population is 14% to 18%, mainly in adults, male prevalence is higher than women, but not significant. The main good hair part is the thigh, have mucinous sex, high differentiation type, dedifferentiation type, polymorphic type. Clinical diagnosis is difficult, and there are no obvious symptoms in the early stage, so the diagnosis should be combined with B ultrasound, MRI, CT, and other auxiliary examinations. The gold standard is pathological examination. In December 2023, our department admitted a patient with a mucinous abdominal mass. The report is as follows. Patient concerns: Does liposarcoma metastasize? Is any chemotherapy required after surgery? Will it ever relapse in the future? What is the survival period after surgery? Diagnosis: Mucinous liposarcoma. Interventions: Surgical resection of the sarcoma. Results: The nodule sample was 33 * 28 * 13 cm, with complete capsule, gray and yellow sections, fine texture, soft, gray, red, grayish, and yellow mucoid nodules in some areas, and the maximum diameter of the nodules was 21cm. Immunohistochemistry was: CD34 (+), CDK 4 (+), CK (−), Desmin (weak +), Ki67 (index 5%), MDM 2 (−), p16 (weak +), S-100P (+), Vimentin (+), BCL-2 (+). He was also sent to the Department of Pathology of Peking Union Medical College Hospital for consultation with Professor Lu Zhaohui, whose consultation opinion was in line with myxoliposarcoma. Conclusion: Retroperitoneal liposarcoma is a common retroperitoneal tumor, but it is relatively rare in clinical practice; the overall morbidity is low, mainly manifested as abdominal pain and abdominal distension, abdominal distension, and a long course of disease; it is not sensitive to radiotherapy and chemotherapy, and should be closely follow up by CT examination to understand the recurrence and metastasis.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference18 articles.

1. A case of retroperitoneal giant dedifferentiated liposarcoma.;An;J Clin Surg,2022

2. Expert consensus on the diagnosis and treatment of retroperitoneal liposarcoma (2016).;Chin J Minim Invasive Surg,2016

3. Difficulties of diagnosisin retroperitoneal tumors.;Venter;Rorn J Morphol Embryol,2013

4. The 2020 WHO classification of soft tissue tumours: news and perspectives.;Sbaraglia;Pathologica,2021

5. Ultrasound findings and pathological analysis of liposarcoma.;Qin;Chin J Clinicians,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3